Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $129.4M $143.1M $133.0M $189.2M $364.9M $221.6M $153.3M $136.1M
Depreciation & Amortization $71.6M $72.4M $71.4M $54.9M $34.9M $33.4M $32.9M $29.6M
Depreciation $58.3M $60.8M $61.6M $46.5M $27.1M $25.5M $25.7M $22.7M
Amortization $8.1M $8.4M $8.6M $8.4M $7.8M $7.9M $7.1M $6.9M
Stock-Based Compensation $19.3M $8.9M $7.4M $17.5M $32.6M $21.4M $15.5M $10.8M
Net Cash from Operating Activities $302.6M $275.3M $322.1M $-56.5M $530.2M $311.0M $224.3M $187.9M
Investing Activities
Capital Expenditures $60.2M $50.2M $56.6M $101.5M $185.1M $96.6M $41.8M $53.8M
Business Acquisitions $31.7M $8.7M $0 $0 $0 $12.6M $11.7M $0
Net Cash from Investing Activities $-92.0M $-57.9M $-60.8M — $-193.7M $-104.9M $-71.2M $-53.8M
Financing Activities
Dividends Paid $76.1M $78.4M $81.2M $81.4M $70.5M $48.4M $36.6M $31.2M
Stock Repurchases $71.7M $247.2M $164.1M $45.7M $140.9M $201.5M $67.1M $58.5M
Net Cash from Financing Activities $-159.6M $-134.7M $-235.9M — $-120.7M $-163.9M $-107.0M $-69.0M
Net Change in Cash $69.2M $67.9M $939.0K $-236.7M $205.1M $47.1M $42.6M $72.3M
Free Cash Flow $242.4M $225.0M $265.5M $-157.9M $345.1M $214.3M $182.5M $134.1M
← Newer Page 2 of 3 Older →